Clinical Clarity

One Molecule at a Time

Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.

Learn More

Clinical Lab Testing Services
Clinical Diagnostics System

Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Upcoming Events

  • Jul 31, 2013 - Jul 30, 2014:
    Ultrasensitive Immunoassays for Translation of Biomarkers from Discovery to the Clinic
    Translating basic research into the clinic requires simple, fast, and cost-effective technologies… On Demand
    Details

News Articles

  • Alameda’s Singulex Named as Innovation Award Finalist
    More
  • Singulex Digital Single Molecule Counting: A new concept in assay detection
    More

Press Releases

March 31, 2014: Sony DADC and Singulex Announce Strategic Partnership for Proprietary Detection Vessels More
March 25, 2014: Singulex, in Partnership with Tecan, Commences Commercial Development of Ultrasensitive Sgx ClarityTM System for in vitro Diagnostics Market More